We hypothesize that overexpression of this protein can rescue the developmental and epileptic phenotype through exploiting both the chaperoning and recycling capabilities of Plic-1, and this is an exciting direction of therapeutic development for LGS that employs the Gabrb3+/N328D mouse in our future study. Here, GABRB3 is linked to Lennox-Gastaut syndrome.